GAMMADELTA THERAPEUTICS LTD

Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
G

GAMMADELTA THERAPEUTICS LTD

Research and experimental development on biotechnology

Founded 17 Jun 2016 Active London, England 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 18 Apr 2026 Next due 31 Mar 2026 2 months overdue
Confirmation Submitted 19 Jun 2025 Next due 30 Jun 2026 1 month remaining
Net assets £131M £13M 2024 year on year
Total assets £158M £17M 2024 year on year
Total Liabilities £27M £4M 2024 year on year
Charges 1
1 satisfied

Contact & Details

Contact

Registered Address

1 Kingdom Street London W2 6BD England

Email

info@example.com

Website

www.example.com

Full company profile for GAMMADELTA THERAPEUTICS LTD (10238425), an active company based in London, England. Incorporated 17 Jun 2016. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type full
Next accounts 31 Mar 2025
Due by 31 Mar 2026 2 months overdue

Balance Sheet & P&L (2020–2024)

Cash in Bank

N/A

Net Assets

£130.90M

Decreased by £12.55M (-9%)

Total Liabilities

£26.82M

Decreased by £4.20M (-14%)

Turnover

£2.81M

Decreased by £20.15M (-88%)

Employees

N/A

Debt Ratio

17%

Decreased by 1 (-6%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 2Sept 2016Seed
Investor 4Sept 2016Seed
Investor 5Sept 2016Seed

Share Capital

Share Capital

Share allotments and capital structure

2 Allotments 159,384 Shares £159.384 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
5 Apr 202214,384£14.384£0.001
24 Jun 2016145,000£145£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Takeda Pharmaceutical Company Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Takeda Pharmaceutical Company Limited

Japan

Active
Notified 8 May 2017
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Abingworth Llp

Ceased 24 Jul 2017

Ceased
Ceased

Group Structure

Group Structure

GAMMADELTA THERAPEUTICS LTD Current Company

Charges

Charges

1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Apr 2026AccountsAnnual accounts made up to 31 Mar 2025
18 Apr 2026AccountsAnnual accounts made up to 31 Mar 2025
18 Jul 2025AccountsAnnual accounts made up to 31 Mar 2024
19 Jun 2025Confirmation StatementConfirmation statement made on 16 Jun 2025 with no updates
11 Jun 2025GazetteGazette Filings Brought Up To Date
18 Apr 2026 Accounts

Annual accounts made up to 31 Mar 2025

18 Apr 2026 Accounts

Annual accounts made up to 31 Mar 2025

18 Jul 2025 Accounts

Annual accounts made up to 31 Mar 2024

19 Jun 2025 Confirmation Statement

Confirmation statement made on 16 Jun 2025 with no updates

11 Jun 2025 Gazette

Gazette Filings Brought Up To Date

Recent Activity

Latest Activity

Annual accounts made up to 31 Mar 2025

1 months ago on 18 Apr 2026

Annual accounts made up to 31 Mar 2025

1 months ago on 18 Apr 2026

Annual accounts made up to 31 Mar 2024

10 months ago on 18 Jul 2025

Confirmation statement made on 16 Jun 2025 with no updates

11 months ago on 19 Jun 2025

Gazette Filings Brought Up To Date

11 months ago on 11 Jun 2025